市場調査レポート

商品コード

1565605

白斑治療の世界市場：タイプ・治療法・エンドユーザー・地域別の予測 (～2030年)

Global Vitiligo Treatment Market Research Report Information by Type, By Treatment, By End-User, and Region -Forecast till 2030

出版日: 2024年08月10日
発行: Market Research Future
ページ情報: 英文 123 Pages
納期: 即納可能

価格

PDF & Excel (Single User License)

USD 4,950 741,708円

レポートPDF、Excelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Multi User License)

USD 5,950 891,548円

レポートPDF、Excelを同一企業内の最大15名がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。

PDF & Excel (Enterprise License)

USD 7,250 1,086,340円

レポートPDF、Excelを同一企業内のすべての方がご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDF、Excelの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.84円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の白斑治療の市場規模は予測期間中に6.20%のCAGRで成長すると予測されています。同市場は、白斑の有病率の増加、美的魅力の重要性と認識の向上、治療オプションの進歩により成長を遂げています。

一人当たり所得の増加、デジタルプラットフォームの導入、さまざまな美容治療に対する意識の高まりの結果、近年、消費者の美意識が大幅に高まっています。2015年から2019年にかけて、ISAPS (International Society of Aesthetic Plastic Surgery) は、外科手術以外の施術の世界総数が27.3％増加したと報告しています。また、ASPS (American Society of Plastic Surgeons) は、2000年から2017年にかけて、低侵襲美容施術の数が約200％増加したと報告しています。さらに、2018年には約1,590万件の低侵襲美容施術が実施され、2017年から2％増加しました。

地域別展望

2023年には、北米の白斑治療市場が最大の市場シェアを示しました。皮膚疾患に対する認識が高まり、より洗練された医療インフラが整備された結果です。同地域がR&Dに力を入れている結果、先進的な光線療法、生物学的製剤、外用薬などの革新的な治療が導入されています。

欧州の市場シェアは、白斑治療の統合に向けた動向と有利な医療政策の結果、第2位になると予想されています。フランスは欧州地域でもっとも急成長している市場であると予測され、ドイツは最大のシェアを保持しているとされています。

2024年から2032年にかけて、アジア太平洋地域の白斑治療市場がもっとも急速な成長を遂げると予測されています。これは、医療費の増加と医療インフラの改善により、先進治療へのアクセスが向上した結果です。さらに、尋常性白斑の有病率の増加や美容・皮膚科治療に対する需要の高まりも市場促進要因となっています。

当レポートでは、世界の白斑治療の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 3 GLOBAL VITILIGO TREATMENT MARKET, FOR SEGMENTAL VITILIGO, BY REGION, 2019-2030 (USD BILLION)
TABLE 4 GLOBAL VITILIGO TREATMENT MARKET, FOR NON-SEGMENTAL VITILIGO, BY REGION, 2019-2030 (USD BILLION)
TABLE 5 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 6 GLOBAL VITILIGO TREATMENT MARKET, FOR THERAPY, BY REGION, 2019-2030 (USD BILLION)
TABLE 7 GLOBAL VITILIGO TREATMENT MARKET, FOR DEPIGMENTATION, BY REGION, 2019-2030 (USD BILLION)
TABLE 8 GLOBAL VITILIGO TREATMENT MARKET, FOR LIGHT, BY REGION, 2019-2030 (USD BILLION)
TABLE 9 GLOBAL VITILIGO TREATMENT MARKET, FOR SURGERY, BY REGION, 2019-2030 (USD BILLION)
TABLE 10 GLOBAL VITILIGO TREATMENT MARKET, FOR SKIN GRAFTING, BY REGION, 2019-2030 (USD BILLION)
TABLE 11 GLOBAL VITILIGO TREATMENT MARKET, FOR BLISTER GRAFTING, BY REGION, 2019-2030 (USD BILLION)
TABLE 12 GLOBAL VITILIGO TREATMENT MARKET, FOR MICRO-PIGMENTATION, BY REGION, 2019-2030 (USD BILLION)
TABLE 13 GLOBAL VITILIGO TREATMENT MARKET, FOR MEDICATION, BY REGION, 2019-2030 (USD BILLION)
TABLE 14 GLOBAL VITILIGO TREATMENT MARKET, FOR TOPICAL CORTICOSTEROIDS, BY REGION, 2019-2030 (USD BILLION)
TABLE 15 GLOBAL VITILIGO TREATMENT MARKET, FOR IMMUNOSUPPRESSIVE, BY REGION, 2019-2030 (USD BILLION)
TABLE 16 GLOBAL VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 17 GLOBAL VITILIGO TREATMENT MARKET, FOR HOSPITALS, BY REGION, 2019-2030 (USD BILLION)
TABLE 18 GLOBAL VITILIGO TREATMENT MARKET, FOR AMBULATORY CLINICS, BY REGION, 2019-2030 (USD BILLION)
TABLE 19 GLOBAL VITILIGO TREATMENT MARKET, FOR OTHERS, BY REGION, 2019-2030 (USD BILLION)
TABLE 20 GLOBAL: VITILIGO TREATMENT MARKET, BY REGION, 2019-2030 (USD BILLION)
TABLE 21 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 22 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 23 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 24 NORTH AMERICA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 25 NORTH AMERICA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 26 NORTH AMERICA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 27 NORTH AMERICA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 28 US: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 29 US: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 30 US: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 31 US: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 32 US: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 33 US: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 34 CANADA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 35 CANADA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 36 CANADA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 37 CANADA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 38 CANADA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 39 CANADA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 40 EUROPE: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 41 EUROPE: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 42 EUROPE: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 43 EUROPE: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 44 EUROPE: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 45 EUROPE: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 46 EUROPE: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 47 GERMANY: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 48 GERMANY: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 49 GERMANY: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 50 GERMANY: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 51 GERMANY: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 52 GERMANY: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 53 FRANCE: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 54 FRANCE: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 55 FRANCE: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 56 FRANCE: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 57 FRANCE: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 58 FRANCE: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 59 UK: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 60 UK: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 61 UK: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 62 UK: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 63 UK: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 64 UK: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 65 ITALY: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 66 ITALY: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 67 ITALY: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 68 ITALY: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 69 ITALY: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 70 ITALY: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 71 SPAIN: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 72 SPAIN: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 73 SPAIN: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 74 SPAIN: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 75 SPAIN: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 76 SPAIN: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 77 REST OF EUROPE: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 78 REST OF EUROPE: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 79 REST OF EUROPE: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 80 REST OF EUROPE: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 81 REST OF EUROPE: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 82 REST OF EUROPE: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 83 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 84 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 85 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 86 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 87 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 88 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 89 ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 90 CHINA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 91 CHINA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 92 CHINA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 93 CHINA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 94 CHINA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 95 CHINA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 96 JAPAN: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 97 JAPAN: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 98 JAPAN: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 99 JAPAN: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 100 JAPAN: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 101 JAPAN: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 102 INDIA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 103 INDIA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 104 INDIA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 105 INDIA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 106 INDIA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 107 INDIA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 108 SOUTH KOREA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 109 SOUTH KOREA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 110 SOUTH KOREA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 111 SOUTH KOREA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 112 SOUTH KOREA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 113 SOUTH KOREA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 114 AUSTRALIA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 115 AUSTRALIA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 116 AUSTRALIA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 117 AUSTRALIA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 118 AUSTRALIA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 119 AUSTRALIA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 120 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 121 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 122 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 123 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 124 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 125 REST OF ASIA-PACIFIC: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 126 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY COUNTRY, 2019-2030 (USD BILLION)
TABLE 127 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 128 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 129 REST OF THE WORLD: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 130 REST OF THE WORLD: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 131 REST OF THE WORLD: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 132 REST OF THE WORLD: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 133 MIDDLE EAST: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 134 MIDDLE EAST: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 135 MIDDLE EAST: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 136 MIDDLE EAST: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 137 MIDDLE EAST: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 138 MIDDLE EAST: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 139 AFRICA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 140 AFRICA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 141 AFRICA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 142 AFRICA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 143 AFRICA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 144 AFRICA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 145 LATIN AMERICA: VITILIGO TREATMENT MARKET, BY TYPE, 2019-2030 (USD BILLION)
TABLE 146 LATIN AMERICA: VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2019-2030 (USD BILLION)
TABLE 147 LATIN AMERICA: VITILIGO TREATMENT MARKET, FOR THERAPY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 148 LATIN AMERICA: VITILIGO TREATMENT MARKET, FOR SURGERY, BY TYPE, 2019-2030 (USD BILLION)
TABLE 149 LATIN AMERICA: VITILIGO TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2019-2030 (USD BILLION)
TABLE 150 LATIN AMERICA: VITILIGO TREATMENT MARKET, BY END USER, 2019-2030 (USD BILLION)
TABLE 151 MAJOR MANUFACTURERS IN VITILIGO TREATMENT MARKET
TABLE 152 MOST ACTIVE PLAYER IN VITILIGO TREATMENT MARKET
TABLE 153 PRODUCT APPROVALS/PRODUCT LAUNCHES/DRUG PIPELINE
TABLE 154 MERGERS & ACQUISITIONS
TABLE 155 INCYTE: PRODUCTS OFFERED
TABLE 156 INCYTE: KEY DEVELOPMENTS
TABLE 157 BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED
TABLE 158 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 159 DR. REDDY'S LABORATORIES LTD.: PRODUCTS OFFERED
TABLE 160 STRATA SKIN SCIENCES: PRODUCTS OFFERED
TABLE 161 STRATA SKIN SCIENCES: KEY DEVELOPMENTS
TABLE 162 CLINUVEL PHARMACEUTICALS LTD: PRODUCTS OFFERED
TABLE 163 ISSAR PHARMACEUTICALS PVT. LTD.: PRODUCTS OFFERED
TABLE 164 KERNEL MEDICAL EQUIPMENT CO., LTD.: PRODUCTS OFFERED
TABLE 165 LIGHTSOURCES: PRODUCTS OFFERED
TABLE 166 ROIVANT SCIENCES LTD.: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 GLOBAL VITILIGO TREATMENT MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: GLOBAL VITILIGO TREATMENT MARKET
FIGURE 4 DRIVERS: IMPACT ANALYSIS
FIGURE 5 RESTRAINT: IMPACT ANALYSIS
FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL VITILIGO TREATMENT MARKET
FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL VITILIGO TREATMENT MARKET
FIGURE 8 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE, 2022 AND 2030 (USD BILLION)
FIGURE 9 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE, 2022 AND 2030 (USD BILLION)
FIGURE 10 GLOBAL VITILIGO TREATMENT MARKET, BY END USER, 2022 AND 2030 (USD BILLION)
FIGURE 11 GLOBAL: VITILIGO TREATMENT MARKET, BY REGION 2022 AND 2030 (USD BILLION)
FIGURE 12 GLOBAL: VITILIGO TREATMENT MARKET SHARE (%), BY REGION,
FIGURE 13 NORTH AMERICA: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY
FIGURE 14 EUROPE: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY
FIGURE 15 ASIA-PACIFIC: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY,
FIGURE 16 REST OF THE WORLD: VITILIGO TREATMENT MARKET SHARE (%), BY COUNTRY,
FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 18 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN VITILIGO TREATMENT MARKET
FIGURE 19 GLOBAL VITILIGO TREATMENT MARKET: COMPETITIVE LANDSCAPE
FIGURE 20 MAJOR PLAYERS SALES & OPERATING INCOME,
FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE,
FIGURE 22 INCYTE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 INCYTE: SWOT ANALYSIS
FIGURE 24 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS
FIGURE 26 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
FIGURE 28 DR. REDDY'S LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 DR. REDDY'S LABORATORIES LTD.: SWOT ANALYSIS
FIGURE 30 STRATA SKIN SCIENCES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 CLINUVEL PHARMACEUTICALS LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 CLINUVEL PHARMACEUTICALS LTD: SWOT ANALYSIS
FIGURE 33 ROIVANT SCIENCES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ROIVANT SCIENCES LTD.: PRODUCTS OFFERED

Product Code: MRFR/HC/6970-CR

Global Vitiligo Treatment Market Research Report Information by Type (Segmental Vitiligo, Non-Segmental Vitiligo), By Treatment (Therapy, Surgery, Medication), By End-User (Hospitals, Ambulatory Clinics, Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World)-Forecast till 2030

Market Overview

The Vitiligo Treatment Market industry is anticipated to experience a compound annual growth rate (CAGR) of 6.20% during the forecast period. The market is experiencing growth due to the increasing prevalence of vitligo, the increasing significance of aesthetic appeal and awareness, and the advancements in treatment options.

As a result of the increasing per capita income, the adoption of digital platforms, and the increasing awareness of various aesthetic treatments, there has been a substantial increase in beauty consciousness among consumers in recent years. Between 2015 and 2019, the International Society of Aesthetic Plastic Surgery (ISAPS) reported a 27.3% increase in the global total of non-surgical procedures. Furthermore, the American Society of Plastic Surgeons (ASPS) reported that the number of minimally invasive aesthetic procedures increased by approximately 200% from 2000 to 2017. Additionally, in 2018, approximately 15.9 million minimally invasive cosmetic procedures were conducted, representing a 2% increase from 2017.

Market Segment Insights

Segmental Vitiligo and Non-Segmental Vitiligo comprise the Vitiligo Treatment Market segmentation by Type.

A treatment that encompasses therapy, surgery, and medication is the basis for market segmentation.

The end-user segmentation of the market is based on Hospitals, Ambulatory Clinics, and Others.

Regional Perspectives

The market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World by region. In 2023, the North American Vitiligo Treatment Market held the greatest market share. As a result of the growing awareness of skin disorders and the development of a more sophisticated healthcare infrastructure. Innovative treatments, such as advanced phototherapy, biologics, and topical medications, have been introduced as a result of the region's strong emphasis on research and development.

The market share of the European Vitiligo Treatment Market is anticipated to be the second largest, as a result of the trend toward the integration of Vitiligo Treatment and the favorable health policies. Additionally, the France Vitiligo Treatment Market is anticipated to be the fastest-growing market in the European region, while the German Vitiligo Treatment Market was attributed to holding the largest market share.

From 2024 to 2032, the Asia-Pacific Vitiligo Treatment market is anticipated to experience the most rapid growth. This is the result of improved access to advanced therapies, which is facilitated by rising healthcare expenditures and the improvement of healthcare infrastructure. Additionally, the increasing prevalence of vitiligo and the increasing demand for cosmetic and dermatological remedies are substantial market drivers.

The Middle East, Africa, and Latin America comprise the Rest of the World. The primary factors that are influencing the expansion of Vitiligo Treatment in the Middle East and Africa. The Middle East and Africa region has encountered Increased global awareness and destigmatization of vitiligo are resulting in a higher demand for effective treatments and an increase in the number of diagnoses.

Major Players

Incyte (US), Bausch Health Companies Inc (Canada), Koninklijke Philips N.V. (Netherlands), Reddy's Laboratories Ltd (India), Strata Skin Sciences (US), Clinuvel Pharmaceuticals Ltd (Australia), ISSAR Pharmaceuticals Pvt. Ltd (India), Kernel Medical Equipment CO., LTD (China), LightSources (US), and Roivant Sciences Ltd. (Switzerland) are among the key companies in the Vitiligo Treatment Market.

1 EXECUTIVE SUMMARY

1.1 OVERVIEW
- 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTION

2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
- 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
- 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
- 3.6.1 BOTTOM-UP APPROACH
- 3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW
4.2 DRIVERS
- 4.2.1 GROWING IMPORTANCE OF THE AESTHETIC APPEAL AND AWARENESS
- 4.2.2 INCREASING PREVALENCE OF VITLIGO
4.3 RESTRAINTS
- 4.3.1 LACK OF TRAINED PROFESSIONALS
4.4 OPPORTUNITIES
- 4.4.1 RISING NUMBER OF CLINICAL TRIALS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS
- 5.1.1 R&D
- 5.1.2 MANUFACTURING
- 5.1.3 DISTRIBUTION & SALES
- 5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
- 5.2.1 THREAT OF NEW ENTRANTS
- 5.2.2 BARGAINING POWER OF SUPPLIERS
- 5.2.3 THREAT OF SUBSTITUTES
- 5.2.4 BARGAINING POWER OF BUYERS
- 5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE VITILIGO TREATMENT MARKET
- 5.3.1 IMPACT ON SUPPLY CHAIN
- 5.3.2 IMPACT ON REGION
- 5.3.3 IMPACT ON DEMAND AND SUPPLY

6 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE

6.1 OVERVIEW
6.2 SEGMENTAL VITILIGO
6.3 NON-SEGMENTAL VITILIGO

7 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE

7.1 OVERVIEW
7.2 THERAPY
- 7.2.1 DEPIGMENTATION
- 7.2.2 LIGHT
7.3 SURGERY
- 7.3.1 SKIN GRAFTING
- 7.3.2 BLISTER GRAFTING
- 7.3.3 MICRO-PIGMENTATION
7.4 MEDICATION
- 7.4.1 TOPICAL CORTICOSTEROIDS
- 7.4.2 IMMUNOSUPPRESSIVE

8 GLOBAL VITILIGO TREATMENT MARKET, BY END USER

8.1 OVERVIEW
8.2 HOSPITALS
8.3 AMBULATORY CLINICS
8.4 OTHERS

9 GLOBAL VITILIGO TREATMENT MARKET, BY REGION

9.1 OVERVIEW
9.2 NORTH AMERICA
- 9.2.1 US
- 9.2.2 CANADA
9.3 EUROPE
- 9.3.1 GERMANY
- 9.3.2 FRANCE
- 9.3.3 UK
- 9.3.4 ITALY
- 9.3.5 SPAIN
- 9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
- 9.4.1 CHINA
- 9.4.2 JAPAN
- 9.4.3 INDIA
- 9.4.4 SOUTH KOREA
- 9.4.5 AUSTRALIA
- 9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
- 9.5.1 MIDDLE EAST
- 9.5.2 AFRICA
- 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN VITILIGO TREATMENT MARKET
10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN VITILIGO TREATMENT MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 10.6.1 PRODUCT APPROVALS/PRODUCT LAUNCHES/DRUG PIPELINE
- 10.6.2 MERGERS & ACQUISITIONS
10.7 MAJOR PLAYERS SALES ANALYSIS
- 10.7.1 SALES & OPERATING INCOME,
- 10.7.2 MAJOR PLAYERS R&D ANALYSIS,

11 COMPANY PROFILE

11.1 INCYTE
- 11.1.1 COMPANY OVERVIEW
- 11.1.2 FINANCIAL OVERVIEW
- 11.1.3 PRODUCTS OFFERED
- 11.1.4 KEY DEVELOPMENTS
- 11.1.5 SWOT ANALYSIS
- 11.1.6 KEY STRATEGIES
11.2 BAUSCH HEALTH COMPANIES INC.
- 11.2.1 COMPANY OVERVIEW
- 11.2.2 FINANCIAL OVERVIEW
- 11.2.3 PRODUCTS OFFERED
- 11.2.4 KEY DEVELOPMENTS
- 11.2.5 SWOT ANALYSIS
- 11.2.6 KEY STRATEGIES
11.3 KONINKLIJKE PHILIPS N.V.
- 11.3.1 COMPANY OVERVIEW
- 11.3.2 FINANCIAL OVERVIEW
- 11.3.3 PRODUCTS OFFERED
- 11.3.4 KEY DEVELOPMENTS
- 11.3.5 SWOT ANALYSIS
- 11.3.6 KEY STRATEGIES
11.4 DR. REDDY'S LABORATORIES LTD.
- 11.4.1 COMPANY OVERVIEW
- 11.4.2 FINANCIAL OVERVIEW
- 11.4.3 PRODUCTS OFFERED
- 11.4.4 KEY DEVELOPMENTS
- 11.4.5 SWOT ANALYSIS
- 11.4.6 KEY STRATEGIES
11.5 STRATA SKIN SCIENCES
- 11.5.1 COMPANY OVERVIEW
- 11.5.2 FINANCIAL OVERVIEW
- 11.5.3 PRODUCTS OFFERED
- 11.5.4 KEY DEVELOPMENTS
- 11.5.5 KEY STRATEGIES
11.6 CLINUVEL PHARMACEUTICALS LTD
- 11.6.1 COMPANY OVERVIEW
- 11.6.2 FINANCIAL OVERVIEW
- 11.6.3 PRODUCTS OFFERED
- 11.6.4 KEY DEVELOPMENTS
- 11.6.5 SWOT ANALYSIS
- 11.6.6 KEY STRATEGIES
11.7 ISSAR PHARMACEUTICALS PVT. LTD.
- 11.7.1 COMPANY OVERVIEW
- 11.7.2 FINANCIAL ANALYSIS
- 11.7.3 PRODUCTS OFFERED
- 11.7.4 KEY DEVELOPMENTS
- 11.7.5 KEY STRATEGIES
11.8 KERNEL MEDICAL EQUIPMENT CO., LTD.
- 11.8.1 COMPANY OVERVIEWS
- 11.8.2 FINANCIAL OVERVIEW
- 11.8.3 PRODUCTS OFFERED
- 11.8.4 KEY DEVELOPMENTS
- 11.8.5 KEY STRATEGIES
11.9 LIGHTSOURCES
- 11.9.1 COMPANY OVERVIEW
- 11.9.2 FINANCIAL ANALYSIS
- 11.9.3 PRODUCTS OFFERED
- 11.9.4 KEY DEVELOPMENTS
- 11.9.5 KEY STRATEGIES
11.10 ROIVANT SCIENCES LTD.
- 11.10.1 COMPANY OVERVIEW
- 11.10.2 FINANCIAL ANALYSIS
- 11.10.3 PRODUCTS OFFERED
- 11.10.4 KEY DEVELOPMENTS
- 11.10.5 PRODUCTS OFFERED
- 11.10.6 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES
12.2 RELATED REPORTS

白斑治療の世界市場：タイプ・治療法・エンドユーザー・地域別の予測 (～2030年)

Global Vitiligo Treatment Market Research Report Information by Type, By Treatment, By End-User, and Region -Forecast till 2030

目次

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の白斑治療市場：タイプ別

第7章世界の白斑治療市場：治療タイプ別

第8章世界の白斑治療市場：エンドユーザー別

第9章世界の白斑治療市場：地域別

第10章競合情勢

第11章企業プロファイル

第12章付録

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE

7 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE

8 GLOBAL VITILIGO TREATMENT MARKET, BY END USER

9 GLOBAL VITILIGO TREATMENT MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILE

12 APPENDIX

白斑治療の世界市場：タイプ・治療法・エンドユーザー・地域別の予測 (～2030年)

Global Vitiligo Treatment Market Research Report Information by Type, By Treatment, By End-User, and Region -Forecast till 2030

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

第5章 市場要因分析

第6章 世界の白斑治療市場：タイプ別

第7章 世界の白斑治療市場：治療タイプ別

第8章 世界の白斑治療市場：エンドユーザー別

第9章 世界の白斑治療市場：地域別

第10章 競合情勢

第11章 企業プロファイル

第12章 付録

LIST OF TABLES

LIST OF FIGURES

Market Overview

Major Players

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE

7 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE

8 GLOBAL VITILIGO TREATMENT MARKET, BY END USER

9 GLOBAL VITILIGO TREATMENT MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILE

12 APPENDIX

第1章エグゼクティブサマリー

第2章市場概要

第3章調査手法

第4章市場力学

第5章市場要因分析

第6章世界の白斑治療市場：タイプ別

第7章世界の白斑治療市場：治療タイプ別

第8章世界の白斑治療市場：エンドユーザー別

第9章世界の白斑治療市場：地域別

第10章競合情勢

第11章企業プロファイル

第12章付録